Blood Nitrate/Nitrite Concentrations Following Acute Ingestion of Resync in Men and Women

Completed · Not applicable · Has a placebo group

Conditions studied: Healthy

In brief

This study evaluates acute ingestion of the dietary supplement Resync on blood nitrate/nitrite concentrations in a sample of men and women. This will be a crossover trial in which participants take all 4 conditions: 1) 7.5g Resync, 2) 15g Resync, 3) 20g Resync+collagen, 4) placebo.

Key facts

Study ID

NCT04125940

Run by

University of Memphis

People needed

20

Starts

2019-10-14

Expected to finish

2019-12-30

Last updated by the study team

2021-04-28

Who can join

Age: 18 and older, up to 50. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• BMI 18 - 29.9 kg/m2
• Non-smoker
• Non-vegan
• Not using nitrate-based dietary supplements

You may not qualify if…

• Diagnosed history of diabetes
• Diagnosed history of cardiovascular disease
• Diagnosed history of neurological disease
• Pregnant females

Where it is running

• Center for Nutraceutical and Dietary Supplement Research — Memphis, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.